North America Biodefense Market

North America, the biodefense market, is anticipated to reach US$ 3,357.83 Mn in 2027 from US$ 1,569.29 Mn in 2019. The market is projected to grow with a CAGR of 10.1% from 2020-2027.

Disease outbreaks are usually caused by an infection, transmitted through person-to-person contact, animal-to-person contact, or from the environment or other media. Emerging infectious diseases are infections that have recently appeared within a population and are rapidly increasing or threaten to grow shortly. The World Health Organization warned in its 2007 report that infectious diseases are emerging at a rate that has not been seen before. Since the 1970s, about 40 infectious diseases have been discovered, including SARS, MERS, Ebola, avian flu, swine flu, zika, and most recently, coronavirus. Moreover, as per CDC estimates, between 2016 and 2017, nearly 30 Million people suffered from influenza in the U.S. Biodefense techniques, such as vaccinations against influenza; helps reduce the illness by 17% and medical visits and hospitalizations by 18 to 19% respectively. The growing prevalence of Ebola and Zika virus infections is also likely to contribute to the market development. For instance, due to coronavirus outbreak, more than 210,000 cases have now been reported to WHO, and more than 9,000 people have lost their lives as of 20 March 2020. Further, on March 18, 2020 Emergent BioSolutions signed development and manufacturing agreement with Vaxart for their experimental oral vaccine candidate for Coronavirus Disease.

The release of pathogenic agents such as anthrax or smallpox, biological toxins, chemical weapons such as nerve gas, or radioactive substances caused public threats in the past. In order to prevent such outbreaks, the government has planned various strategies, For instance, the NIH‐supported research on infectious diseases and biodefense builds and maintains a base of fundamental knowledge about contagious and immune‐related diseases and uses that knowledge to develop new and improved diagnostics, therapeutics, and preventive measures, including vaccines.

The growing prevalence of infectious diseases, such as coronavirus Ebola and zika virus, is likely to boost the investments in the field of biodefense, thereby driving the market growth.

In 2019, the US accounted for the largest market share in North America biodefense market, and it is also expected to grow at a faster pace over the forecast period. US is an economically advanced country, and the country has the presence of various players that are well established in the biotechnology market. Significant funding by the U.S. military and civilian agencies for biodefense is also one of the key factors responsible for the highest revenue share of the region. Hence, considering the mentioned factors, the biodefense market is expected to grow at a significant pace in the US during the forecast period.

US Biodefense Market Revenue and Forecasts to 2027 (US$ Mn)

Get more information on this report Request Free Sample PDF

North America Biodefense Strategic Insights

Strategic insights for the North America Biodefense provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Biodefense Report Scope

North America Biodefense Regional Insights

The geographic scope of the North America Biodefense refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

NORTH AMERICA CLEAR ALIGNERS – MARKET SEGMENTATION

By Product

• Anthrax
• Small pox
• Botulism
• Radiation/Nuclear
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico

Company Profiles

• Bavarian Nordic
• Alnylam Pharmaceuticals, Inc.
• SIGA Technologies
• Emergent BioSolutions Inc.
• Cleveland Bio Labs
• Dynavax Technologies
• Elusys Therapeutics, Inc.
• Soligenix
• Altimmune
• Pluristem Therapeutics.